Logo image of CADL

CANDEL THERAPEUTICS INC (CADL) Stock Analyst Ratings

NASDAQ:CADL - Nasdaq - US1374041093 - Common Stock - Currency: USD

11.63  -0.58 (-4.75%)

After market: 11.75 +0.12 (+1.03%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CADL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.34. This target is 49.1% above the current price.
CADL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CADL.
In the previous month the buy percentage consensus was at a similar level.
CADL was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

CADL Historical Analyst RatingsCADL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 11.6315.1517.3417.3419.95 - 30.27% 49.10% 49.10% 71.54%

Related screens

CADL Current Analyst RatingCADL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-02-20 Citigroup Initiate Buy
2025-02-19 Canaccord Genuity Initiate Buy
2025-02-07 B of A Securities Initiate Buy
2024-12-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-15 BMO Capital Maintains Outperform -> Outperform
2023-03-31 Credit Suisse Maintains Outperform
2022-12-07 Credit Suisse Maintains Outperform
2022-12-02 HC Wainwright & Co. Initiate Buy
2021-11-19 BMO Capital Initiate Outperform
2021-08-23 UBS Initiate Buy
2021-08-23 Credit Suisse Initiate Outperform
2021-08-23 Jefferies Initiate Buy